Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FXUF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,606
Award facts
- Contract value 100% obligated
- $28,606.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,606.18 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on January 15, 2026, with completion targeted for January 16, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a comprehensive Indefinite Delivery Contract valued at $999,999,999.00 with DLA Troop Support Medical extending through December 2031. This prime vehicle enables the supply of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract portfolio demonstrates consistent capability to deliver diverse medical commodities across multiple therapeutic domains through competitive, firm fixed-price arrangements. This specific order for insulin infusion pods supports the department's diabetes management capabilities and reflects the company's established role as a key supplier of specialized medical devices within the DLA's pharmaceutical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXUF3?
SPE2DR26FXUF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FXUF3 worth?
The government has obligated $28,606 on SPE2DR26FXUF3.
Is contract SPE2DR26FXUF3 an order under another contract?
Yes. SPE2DR26FXUF3 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUF3 competed?
The extent of competition for SPE2DR26FXUF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award